In this review we will report the role of p53 and the main genes involved in its pathways in renal carcinomas, and intend to prove that the proper functioning of p53 is the basis of effective chemotherapy and radiotherapy in anti-cancer treatments. This evidence concerns the gene TP53 and renal carcinoma.